SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
9.68
-0.48 (-4.72%)
At close: Oct 30, 2026, 4:00 PM EDT
9.67
-0.01 (-0.11%)
After-hours: Oct 30, 2026, 7:59 PM EDT
SLS Market Cap
SLS has a market cap or net worth of $1.95 billion as of October 30, 2026. It is the 6,605th most valuable company in the world and the 1,780th biggest in the United States. Its market cap has increased by 792.62% in one year.
Market Cap
1.95B
Enterprise Value
1.82B
1-Year Change
792.62%
Global Rank
Country Rank
#1,780 United States
Category
ChartMarket Cap Chart
Since March 12, 2008, SLS's market cap has increased from $133.40M to $1.95B, an increase of 1,365.39%. That is a compound annual growth rate of 15.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.95B | 263.84% |
| Dec 31, 2025 | 537.00M | 633.61% |
| Dec 31, 2024 | 73.20M | 115.29% |
| Dec 29, 2023 | 34.00M | -30.04% |
| Dec 30, 2022 | 48.60M | -44.65% |
| Dec 31, 2021 | 87.80M | 59.64% |
| Dec 31, 2020 | 55.00M | 163.16% |
| Dec 31, 2019 | 20.90M | -22.88% |
| Dec 31, 2018 | 27.10M | 125.83% |
| Dec 29, 2017 | 12.00M | -43.13% |
| Dec 30, 2016 | 21.10M | -91.13% |
| Dec 31, 2015 | 238.00M | 29.77% |
| Dec 31, 2014 | 183.40M | -64.87% |
| Dec 31, 2013 | 522.00M | 404.35% |
| Dec 31, 2012 | 103.50M | 412.38% |
| Dec 30, 2011 | 20.20M | -57.38% |
| Dec 31, 2010 | 47.40M | -36.12% |
| Dec 31, 2009 | 74.20M | -6.31% |
| Dec 31, 2008 | 79.20M | -40.63% |
| Mar 12, 2008 | 133.40M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Septerna | 2.10B |
| Absci | 2.08B |
| Immunome | 2.06B |
| ADARx Pharmaceuticals | 2.05B |
| Lakefront Biotherapeutics NV | 2.04B |
| Zymeworks | 2.04B |
| Sarepta Therapeutics | 2.02B |
| Generate Biomedicines | 2.01B |